Market Overview:
The global thrombelastograph hemostasis analyzer (TEG) market is expected to register a CAGR of 7.5% during the forecast period, 2018-2030. The growth in the market can be attributed to factors such as rising incidences of bleeding disorders, increasing number of surgical procedures and growing demand for point-of-care testing. However, lack of awareness about TEG technology and its benefits may restrain the growth of this market to some extent. Based on type, the global thrombelastograph hemostasis analyzer (TEG) market is segmented into manual, semi-automatic and fully automatic segments. The fully automatic segment is expected to register highest CAGR during the forecast period owing to its advantages such as high accuracy and speed in results delivery. Based on application, hospitals & clinics accounted for majority share in 2017 and is projected to maintain its dominance during the forecast period due to rising demand for TEG technology from this sector across all regions studied herein.
 Industry Outlook.svg)
Product Definition:
A thrombelastograph hemostasis analyzer (TEG) is a device used to measure the viscoelastic properties of blood. The TEG measures the time it takes for a clot to form and the strength of that clot. This information can be used to help diagnose and treat bleeding disorders.
Manual:
The global manual thrombelastograph hemostasis analyzer (TEG) market size was valued at USD 31.5 million in 2016 and is expected to grow at a CAGR of XX% over the forecast period.
Semi-automatic:
Semi-automatic thrombelastograph hemostasis analyzer is a device used for the measurement of blood coagulation and fibrinolysis in patients. It is an important tool used by physicians to diagnose diseases related to blood clotting such as deep vein thrombosis (DVT) and pulmonary embolism (PE).
Application Insights:
Based on application, the global thrombelastograph hemostasis analyzer (TEG) market is segmented into hospitals and clinics, blood banks, academic institutes, and others. Hospitals and clinics dominated the overall market in terms of revenue in 2017 owing to factors such as increasing prevalence of cardiovascular diseases along with rising geriatric population that suffers from various types of coagulation disorders. Moreover, an increase in number of surgeries coupled with a rise in demand for laboratory tests has contributed to segment growth over the forecast period.
Blood banks are expected to be one of the fastest-growing segments due to factors such as increasing need for blood & its components during surgery or any other medical procedure coupled with high risk involved in Blood Transfusion Medicine which requires fresh frozen plasma or plateletpheresis products within 1 hour time frame which is driving this segment towards growth.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of well-established healthcare infrastructure, high adoption rate of advanced technologies and increasing prevalence of cardiovascular diseases & disorders. Moreover, rising preference for minimally invasive surgeries is also expected to drive the demand for thrombelastograph hemostasis analyzers in this region.
Asia Pacific is expected to witness lucrative growth over the forecast period due to factors such as improving healthcare facilities and reimbursement coverage. In addition, booming medical tourism industry in emerging economies like India and China can also be attributed towards regional growth. Furthermore, government initiatives encouraging R&D activities are anticipated to further fuel market development during the forecast period. For instance, ‘Make in India’ initiative by Indian government encourages domestic manufacturing which will create ample job opportunities over next few years; thus driving regional product demand as well as production base (furthermore creating opportunity for international players).
Growth Factors:
- Increasing incidence of thrombotic disorders: The global incidence of thrombotic disorders is increasing at a significant rate. This is primarily attributed to the changing lifestyle and dietary habits. This, in turn, is fueling the demand for TEG hemostasis analyzers as they are used for the diagnosis and treatment of thrombotic disorders.
- Growing awareness about TEG hemostasis analyzers: There is a growing awareness about TEG hemostasis analyzers among healthcare professionals as well as patients owing to their advantages over other conventional methods of diagnosing and treating thrombotic disorders. This is propelling the growth of the market worldwide.
- Technological advancements in TEG hemostasis analyzers: The technological advancements in TEG hemostasis analyzers are helping them become more efficient and accurate in diagnosing various types of thrombotic disorders. This is resulting in an increase in their demand across hospitals and clinics worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Thrombelastograph Hemostasis Analyzer (TEG) Market Research Report
By Type
Manual, Semi-automatic, Fully Automatic
By Application
Hospitals and Clinics, Blood Banks, Academic Institutes, Others
By Companies
Haemonetics Corporation, Instrumentation Laboratory, Framar Hemologix, Diagnostica Stago, Life Diagnostica, Lepu Medical Technology, Guangzhou Improve Medical Instruments, ChongQing NanFang Numericl Control Equipment
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
171
Number of Tables & Figures
120
Customization Available
Yes, the report can be customized as per your need.
Global Thrombelastograph Hemostasis Analyzer (TEG) Market Report Segments:
The global Thrombelastograph Hemostasis Analyzer (TEG) market is segmented on the basis of:
Types
Manual, Semi-automatic, Fully Automatic
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals and Clinics, Blood Banks, Academic Institutes, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Haemonetics Corporation
- Instrumentation Laboratory
- Framar Hemologix
- Diagnostica Stago
- Life Diagnostica
- Lepu Medical Technology
- Guangzhou Improve Medical Instruments
- ChongQing NanFang Numericl Control Equipment
 Market Overview.svg)
Highlights of The Thrombelastograph Hemostasis Analyzer (TEG) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Manual
- Semi-automatic
- Fully Automatic
- By Application:
- Hospitals and Clinics
- Blood Banks
- Academic Institutes
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Thrombelastograph Hemostasis Analyzer (TEG) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The Thrombelastograph Hemostasis Analyzer (TEG) is a medical device used to measure the level of thrombus in blood. The TEG uses a laser to create an image of the thrombus, which can be used to determine its size and composition. This information can then be used to help diagnose and treat conditions that involve thrombus formation, such as heart disease or stroke.
Some of the key players operating in the thrombelastograph hemostasis analyzer (teg) market are Haemonetics Corporation, Instrumentation Laboratory, Framar Hemologix, Diagnostica Stago, Life Diagnostica, Lepu Medical Technology, Guangzhou Improve Medical Instruments, ChongQing NanFang Numericl Control Equipment.
The thrombelastograph hemostasis analyzer (teg) market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Thrombelastograph Hemostasis Analyzer (TEG) Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Thrombelastograph Hemostasis Analyzer (TEG) Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Thrombelastograph Hemostasis Analyzer (TEG) Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Thrombelastograph Hemostasis Analyzer (TEG) Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Thrombelastograph Hemostasis Analyzer (TEG) Market Size & Forecast, 2020-2028
4.5.1 Thrombelastograph Hemostasis Analyzer (TEG) Market Size and Y-o-Y Growth
4.5.2 Thrombelastograph Hemostasis Analyzer (TEG) Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Manual
5.2.2 Semi-automatic
5.2.3 Fully Automatic
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals and Clinics
6.2.2 Blood Banks
6.2.3 Academic Institutes
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Thrombelastograph Hemostasis Analyzer (TEG) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Thrombelastograph Hemostasis Analyzer (TEG) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Manual
9.6.2 Semi-automatic
9.6.3 Fully Automatic
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals and Clinics
9.10.2 Blood Banks
9.10.3 Academic Institutes
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Manual
10.6.2 Semi-automatic
10.6.3 Fully Automatic
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals and Clinics
10.10.2 Blood Banks
10.10.3 Academic Institutes
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Manual
11.6.2 Semi-automatic
11.6.3 Fully Automatic
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals and Clinics
11.10.2 Blood Banks
11.10.3 Academic Institutes
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Manual
12.6.2 Semi-automatic
12.6.3 Fully Automatic
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals and Clinics
12.10.2 Blood Banks
12.10.3 Academic Institutes
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Manual
13.6.2 Semi-automatic
13.6.3 Fully Automatic
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals and Clinics
13.10.2 Blood Banks
13.10.3 Academic Institutes
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Thrombelastograph Hemostasis Analyzer (TEG) Market: Competitive Dashboard
14.2 Global Thrombelastograph Hemostasis Analyzer (TEG) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Haemonetics Corporation
14.3.2 Instrumentation Laboratory
14.3.3 Framar Hemologix
14.3.4 Diagnostica Stago
14.3.5 Life Diagnostica
14.3.6 Lepu Medical Technology
14.3.7 Guangzhou Improve Medical Instruments
14.3.8 ChongQing NanFang Numericl Control Equipment
